Pharmacokinetic and Pharmacodynamic Interactions with Levofloxacin in Renal Transplant Patients with Suspected Pneumonia
Abstract
Ciprofloxacin, a fluoroquinolone antibiotic, has been linked to an increased risk of acute cellular rejection and drug interactions with the calcineurin inhibitors in renal transplant recipients. Little is known about the effects of levofloxacin. We report our evaluation for pharmacokinetic and pharmacodynamic interaction between levofloxacin and the calcineurin inhibitors. A retrospective review was conducted of renal transplant recipients with known or suspected community acquired pneumonia who received levofloxacin. Patients were assessed for rejection at 90-day follow-up, and compared to a historical ciprofloxacin cohort. Assessment of the drug-drug interaction between levofloxacin and the cal- cineurin inhibitors required stable dose of the immunosuppressants, a baseline trough level, and follow-up levels. Rejec- tion occurred in 1 of the 26 included patients (3.8%), less than the rate in the historical ciprofloxacin group at 4 weeks (28.6%; p=0.012) and 12 weeks (45.2%; p<0.001). There was no significant drug-drug interaction between levofloxacin and cyclosporine (n=8) or tacrolimus (n=6) when trough levels were evaluated. In summary, renal transplant patients re- ceiving levofloxacin for pneumonia did not appear to have a temporally-related elevated risk of ACR or a pharmacoki- netic drug-drug interaction with the calcineurin inhibitors.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.